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We assessed the gut microbial ecology of 11 severely obese patients before and after
bilio-intestinal bypass (BIB). Fecal samples were evaluated for microbial communities
using 16S rDNA Illumina sequencing, real-time PCR targeting functional genes, and gas
chromatography of short chain fatty acids (SCFAs). At 6 months after surgery, subjects
exhibited significant improvements in metabolic markers (body weight, glucose, and lipid
metabolism) compared with baseline. The fecal microbiota of post-surgery individuals
was characterized by an overall decrease of bacterial diversity, with a significant
reduction in Lachnospiraceae, Clostridiaceae, Ruminococcaceae, Eubacteriaceae,
and Coriobacteriaceae. On the contrary, there were significant increases of genera
Lactobacillus, Megasphaera, and Acidaminococcus and the family Enterobacteriaceae.
The pH was decreased in fecal samples from patients after BIB and SCFA profiles
were altered, with lower percentages of acetate and propionate and higher levels of
valerate and hexanoate. Some changes in the bacterial populations were associated with
variations in the patients’ metabolic health parameters, namely Gemmiger and glucose,
Lactobacillus and glucose, and Faecalibacterium and triglycerides. The results from this
study of BIB patients furthers our understanding of the composition of gut microbiota
and the functional changes that may be involved in improving obesity-related conditions
following weight-loss surgery.
Keywords: obesity, gut microbiota, weight loss, bariatric surgery, short chain fatty acids, illumina sequencing, 16S
rRNA
INTRODUCTION
Emerging evidence suggests that microbes that reside in the human gastrointestinal tract may
be involved in the development of obesity. The gut microbiota contributes to weight gain by
promoting storage of calories from the diet as fat (Bäckhed et al., 2004; Turnbaugh et al., 2006).
Several studies in humans and animal models have highlighted differences in the composition of
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the gut microbiota between obese and lean subjects, sometimes
yielding contrasting results (Ley et al., 2005, 2006; Turnbaugh
et al., 2006, 2008, 2009; Schwiertz et al., 2010).
In addition, the association between gut microbiota and
obesity is supported by studies exploring the effects of
bariatric surgery on gut microbial community composition.
This surgery is the most effective current option for treating
severe obesity. By reducing intake or absorption of calories,
surgical intervention produces rapid and long-lasting weight
loss and leads to an improvement of many obesity-related
conditions including type-2 diabetes, hypertension, and high
cholesterol. Zhang et al. (2009) showed that individuals
subjected to Roux-en-Y gastric bypass (RYGB), the most
commonly performed bariatric procedure, have higher numbers
of Enterobacteriaceae bacteria (phylum Proteobacteria)
and lower proportions of Clostridium bacteria (phylum
Firmicutes) and methanogens compared with obese individuals.
A subsequent study by Furet et al. (2010) included obese
subjects before, and 3 and 6 months after RYGB, along with
lean controls. Their results revealed that the prevalence of the
Bacteroides/Prevotella group was lower in obese individuals
compared with lean subjects, but it increased after gastric
surgery. On the contrary, populations of Bifidobacterium and
Lactobacillus/Leuconostoc/Pediococcus decreased after surgery.
At the phylum level, obese patients had a high Firmicutes to
Bacteroidetes ratio before RYGB that decreased 3 and 6 months
postoperatively.
Li et al. (2011) evaluated the effects of RYGB in a non-
obese rat model, and found a striking increase of Proteobacteria
as well as a decrease of both Firmicutes and Bacteroidetes
compared with sham-operated rats. In a key study, Liou et al.
(2013) performed 16S rDNA sequencing in three groups of mice,
which underwent RYGB, sham surgery, or sham surgery coupled
with caloric restriction. The RYGB produced specific changes
in the gut microbial community, i.e., increases in Bacteroidetes,
Verrucomicrobia, and Proteobacteria (Alistipes, Akkermansia,
and Escherichia, respectively, at the genus level) compared
with preoperative levels. Even more important, transferring gut
microbiota from RYGB-mice to germ-free mice induced weight
loss in those animals compared with mice receiving gut samples
from sham-treatedmice. These results suggest that changes in the
population of microbial organisms in the gastrointestinal tract
may mediate some of the beneficial effects of bariatric surgery on
the obese host.
Although RYGB is the most widely used type of bariatric
surgery in the world, there are several available surgical methods
for the treatment of morbidly obese patients. Bilio-intestinal
bypass (BIB) surgery (Eriksson, 1981) consists of disabling
a large portion of the absorptive surfaces within the small
bowel using a shunt between the beginning and end-part, and
connecting the disabled small bowel sling to the gall-bladder to
improve enterohepatic circulation of bile acids. It is unknown
if the changes in microbial ecology observed for RYGB can
be generalized to other types of bariatric surgery; therefore,
we studied fecal samples using 16S rDNA next generation
sequencing to determine the impact of BIB on the gut microbial
composition and environment, and pinpoint the association
between the microbial rearrangement and variations in the host
phenotype.
MATERIALS AND METHODS
Patients
Twenty severely obese patients were evaluated for bariatric
surgery. Eleven subjects were eligible for BIB, by fulfilling
the following criteria: (1) morbid obesity [body mass index
(BMI; in kg m−2) > 40] or severe obesity (BMI > 35), at
least one comorbidity factor (arterial hypertension, diabetes
mellitus) for ≥ 5 years, and resistance to medical treatment;
(2) absence of medical or psychological contraindications for
bariatric surgery; (3) absence of current excessive drinking,
as defined by an average daily consumption of alcohol of 20
g d−1 for women and 30 g d−1 for men, and no history
of excessive drinking for a period > 2 years at any time in
the past 20 years; (4) absence of long-term consumption of
hepatotoxic drugs; and (5) negative screening for chronic liver
diseases, including hepatitis B surface antigen and hepatitis
C virus antibodies, and other known liver diseases such as
Wilson’s disease, hemochromatosis, α1-antitrypsin deficiency, or
autoimmune hepatitis; and (6) no malignant diseases. Informed
written consent was obtained from all patients, and the study
was conducted in conformity with the Helsinki Declaration. The
Ethics Committee of the University Hospital Second University
of Naples, Naples (Italy) approved the study. At baseline, all
patients were evaluated by a multidisciplinary team consisting of
dieticians, gastroenterologists, psychiatrists, an anesthesiologist,
a cardiologist, an endocrinologist, and surgeons. The main
demographic characteristics of patients are reported in Table 1.
Biochemical Evaluation
Subjects fasted overnight for at least 12 h before an antecubital
vein catheter was inserted for blood collection. The following
clinical and biological features were assessed before surgery:
BMI, alanine aminotransferases (ALT), gamma-glutamyl
transpeptidase (γGT), serum triglycerides, cholesterolemia,
fasting blood glucose, and fasting insulin. The energy intake
from diet was obtained by recording individual dietary habits
using the Winfood Software 2.0 package (Medimatica s. r. l.,
Martinsicuro, Italy) program, which calculates calories on the
basis of the quantities and qualities of consumed food (Musso
et al., 2005). Biochemical characteristics of patients at baseline
are reported in Table 1. Parameters related to weight loss,
glucose, and lipid metabolism were also evaluated 6 months after
bariatric surgery.
DNA Extraction
Fecal samples were collected before and 6 months after BIB.
Fifty milli gram of feces were homogenized in 500µl of
10mg/ml lysozyme solution in Tris-sucrose buffer (50mM
Tris-HCl, 40mM EDTA, 0.75M sucrose, pH 8.0) and
incubated for 1 h at 37◦C. The DNA was purified using the
Maxwell R© 16 DNA Purification Kit and the Maxwell R© 16
Instrument (Promega, Madison, WI, USA), according to the
manufacturer’s instructions. The DNA quality was checked by
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TABLE 1 | Baseline demographic and biochemical characteristics of the patients studied.
Patients
1 2 3 4 5 6 7 8 9 10 11
Age (years) 45 56 46 50 48 56 64 58 35 58 41
Sex (F/M) F F F M F M F F F F F
Body weight (kg) 102.40 80.60 125.00 107.00 73.40 113.00 115.00 101.90 110.00 103.00 145.00
BMI (kg m−2 ) 45.90 42.49 51.42 39.21 33.37 44.08 53.91 46.65 53.80 52.41 58.82
Diabetes mellitus (Y/N) Y N Y Y Y N Y N N Y N
Arterial hypertension (Y/N) Y Y Y N Y Y N N Y Y N
Insulinemia (mIU L−1) 16.00 17.00 11.80 24.00 16.00 31.60 11.80 15.00 18.00 21.00 21.90
Glycemia (mg dL−1) 117.00 83.00 129.00 109.00 130.00 99.00 129.00 98.00 92.00 107.00 99.00
ALT (IU L−1) 48.00 61.00 46.00 85.00 54.00 56.00 40.00 78.00 26.00 89.00 64.00
yGT (IU L−1) 38.00 66.00 64.00 54.00 49.00 94.00 84.00 42.00 51.00 43.00 89.00
Total cholesterol (mg dL−1) 179.00 254.00 163.00 154.00 179.00 265.00 163.00 216.00 190.00 237.00 214.00
Triglycerides (mg dL−1) 75.00 188.00 108.00 128.00 202.00 148.00 108.00 101.00 92.00 93.00 141.00
Caloric intake (kcal d−1) 3825.50 2505.40 3297.79 3511.70 3379.00 3809.10 1949.20 3468.21 1410.10 3446.90 2486.30
F, female; M, male; Y, yes; N, no; BMI, body mass index; ALT, alanine aminotransferases; γGT, gamma-glutamyl transpeptidase; IU, international units.
agarose gel electrophoresis and the DNA concentration was
determined using the Qubit HS dsDNA fluorescence assay (Life
Technologies, Carlsbad, CA, USA).
Illumina Sequencing of the 16S rRNA Gene
The V4 region of the bacterial 16S rRNA gene was PCR
amplified using the primers 520F and 802R, which have a
high overall coverage and reasonably good domain specificity
(Klindworth et al., 2013). To allow multiplexing during Illumina
sequencing, both forward and reverse primers were modified
by the addition of a seven base long tag. For each sample the
DNA amplification was performed in triplicate using 5 ng of
DNA for each reaction. The PCR conditions were previously
reported (Claesson et al., 2009). The resulting amplicons were
checked by capillary electrophoresis using a QIAxcel (Qiagen
GmbH, Hilden, Germany). All amplicons were purified using
the MinElute PCR purification kit (Qiagen GmbH, Hilden,
Germany) and then mixed together in equimolar concentrations.
The library was sequenced on a MiSeq System using the MiSeq
Reagent Kit v3 at a 2 × 250 bp read length configuration
Paired-end sequencing (2 × 250 bp) was carried out on an
Illumina MiSeq sequencer (Fasteris, Genève, Switzerland).The
OBITools programs (www.prabi.grenoble.fr/trac/OBITools)
were used to analyze the DNA sequence reads from Illumina,
including assembling pair-end reads, assigning each read
to its original sample, and de-replicating reads into unique
sequences. To denoise the sequence dataset, singletons, and
short sequences (<20 nucleotides) were first removed using
the obigrep command and then the sequences were cleaned
of PCR/sequencing errors and chimeras using the obiclean
program. For taxonomic assignment of sequences, a reference
database was built using the ecoPCR program, which performs an
in silico PCR to extract all sequences from the EMBL nucleotide
library that may be amplified by the 520F/802R primer pair.
The taxons were assigned using the EcoTag program. To further
eliminate putative PCR and/or sequencer artifacts, bioinformatic
TABLE 2 | Real-time PCR primers used to amplify microbial functional
genes.
Primers Target
Gene
Functional Group References
ACS_f/ACS_r acsB Acetogens Gagen et al., 2010
qmcrA-F/qmcrA-R mcrA Methanogens Denman et al., 2007
DRS1F+/DSR-R dsrA Sulfate-reducing bacteria Kondo et al., 2004
BcoAf/BcoAr BcoAT Butyrate-producing bacteria Louis and Flint, 2007
acsB, acetyl-CoA synthase gene; mcrA, methyl-coenzyme M reductase gene; dsrA,
dissimilatory (bi)sulfite reductase gene; BcoAT, butyryl-CoA: acetate CoA transferase
gene.
filtering was used and only sequences with a 90% identity to the
sequences present in GenBank were kept for further analysis.
Real-Time PCR
To determine the presence of hydrogen consumers and butyrate
producers, PCR was performed on fecal DNA using the primer
sets listed in Table 2. The qPCR assays were run using the
StepOne™ Plus Real-Time PCR System (Applied Biosystems,
Foster City, CA, USA). The amplification reaction was carried
out in 20µl containing 2µl DNA, 0.4mM of each forward and
reverse primer, and 10µl of KAPA SYBR FAST qPCR Master
Mix (Kapa Biosystems, Wilmington, MA, USA). Standard curves
were determined using plasmids containing amplified fragments
of acs, dsrA, mcrA, or genomic DNA from reference strains for
BcoAT. Results were expressed as gene copy numbers per gram
wet feces.
Metabolite Analysis
Fecal samples (1.0 g weight) were diluted at a ratio 1:4 (w/v)
in sterile distilled water. The pH of the fecal extracts was
measured using a pH meter (GLP 21; Crison Instruments SA,
Alella, Barcelona, Spain). The samples were then vortexed for
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1min and the homogenate centrifuged at 10,000 × g for 15min
at 10◦C. The supernatant was transferred to a new tube and
stored at −20◦C until analysis. The Megazyme L-and D-Lactate
Assay Kit (Megazyme International Ltd., Wicklow, Ireland)
was used to detect D- and L-lactate. Urea was analyzed at
37◦C via a clinical auto-analyzer (ILAB 600, Instrumentation
Laboratory, Lexington, MA, USA) using a kit purchased from
Instrumentation Laboratory (IL Test). An aliquot of fecal extract
was acidified with 0.12M oxalic acid and frozen at −20◦C until
the analysis of SCFAs. The SCFA concentration in fecal extract
was analyzed by gas chromatography (model 7820A; Agilent
Technologies, Santa Clara, CA, USA) using a capillary column
(30m× 250µm× 0.25µm;DB-FFAP, Agilent J&WGC column)
and a flame-ionization detector. The oven temperature was held
at 60◦C for 5min and then increased by 5◦C/min to 170◦C. The
injector temperature was 250◦C and the detector temperature
was 300◦C. The injector was equipped with a liner of glass
wool to separate particles of dirt from the sample. The samples
were injected by auto-sampler (1µL volume) using the split
method and a 25:1 splitting ratio. Hydrogen and air were used for
flame ionization detection. The carrier gas was nitrogen, with a
constant flow of 1.78mL/min. Pivalic acid was used as an internal
standard.
Statistical Analysis
To verify an adequate sequencing depth of the fecal microbiota,
we performed rarefaction analysis on raw counts using an R-
based protocol (http://www.jennajacobs.org/R/rarefaction.html).
Alpha and beta diversity analysis was performed in R (version
3.1.2) (R Core Team, 2014) using the Vegan package (Oksanen
et al., 2014). To avoid bias due to different sampling depths, we
first rarefied the OTU abundance table by randomly subsampling
each sample to the smallest data size. Differences between
fecal bacterial communities were visualized using non-metric
multidimensional scaling (NMDS) on the basis of the Bray-Curtis
distance matrix. Hierarchical clustering using Spearman rank
correlation distance andWard linkage was performed on relative
abundance values at the genus level using the hclust function
of Vegan. To identify bacterial taxa that were differentially
abundant in the gut microbiota of obese patients before and
after surgery, we utilized the LEfSe algorithm (Segata et al.,
2011) implemented in the Galaxy module (http://huttenhower.
sph.harvard.edu/galaxy/). We used per-sample normalization on
bacterial relative abundance data. The default value of alpha
was 0.05 and the logarithmic LDA score threshold was 2.
A principal component analysis (PCA) was carried out using
the prcomp function in R to explore relationships between
bacterial populations that significantly changed after BIB and
clinical parameters of the host. To investigate associations
among bacterial populations and SCFA concentrations, linear
mixed-effects models were fitted by maximum likelihood (ML)
with the lme function in the nlme R package (Pinheiro
et al., 2013). After standardization to zero mean and unit
variance, bacteria populations were tested as fixed independent
effects, and SCFA concentrations as response variables. To take
into account the repeated-measures design of the experiment,
subjects were modeled as random factors. Likewise, associations
between bacterial groups that significantly changed after BIB
and anthropometric and biochemical measurements, including
dietary caloric intake, were also assessed. The Bonferroni
correction was used as an adjustment method for multiple
testing, with a chosen significance level of P ≤ 0.05 for multiple
comparisons of the associations between bacterial genera and
SCFAs, and of P ≤ 0.20 for multiple comparisons between
bacterial genera and bio-clinical markers. To compare population
means for statistical significance, the Shapiro-Wilks test was used
to check for normality, and paired t-test or Wilcoxon rank-sum
tests were performed using either R or GraphPad Prism version 5
(Graphpad Software, San Diego, CA, USA).
Nucleotide Sequence Accession
The 16S sequence data are publicly available on Dryad repository
(http://dx.doi.org/10.5061/dryad.j82n2).
RESULTS
Bio-Clinical Characteristics of Surgical
Patients
As expected, obese individuals showed a significant reduction
in BMI and body weight 6 months after surgical intervention
(Table 3). Circulating glucose and insulin were also decreased,
which indicated an amelioration of glucose homeostasis, as well
as postoperative triglyceride and total cholesterol concentrations.
An analysis of total food intake showed a drastic caloric
reduction 6 months after surgery compared with the pre-
operative nutritional status (Table 3).
Sequencing Coverage and Estimation of
Fecal Bacterial Diversity
In this study, the bacterial composition of the fecal samples
was examined using an Illumina high-throughput sequencing
technique. We generated a dataset consisting of 1,232,275 filtered
high-quality and classifiable 16S rRNA gene sequences, and the
average number of sequences obtained for each individual was
56,013 (range: from 25,224 to 102,372). All sequences were
clustered with representative sequences, and a 97% sequence
identity cut-off was used. The total number of operational
TABLE 3 | Characteristics of the study population pre- (baseline) and
post-surgery (6 months after bilio-intestinal bypass).
Parameters Pre-Surgery(n = 11) Post-Surgery(n = 11)
Body weight, kg 106.94±19.41 89.21±17.90***
BMI, kg m−2 47.46±7.46 40.68±5.88***
Insulin, mIU L−1 18.55±5.80 13.55±2.16**
Glucose,mg dL−1 108.36±16.10 93.36±10.93***
Cholesterol,mg dL−1 201.27±38.45 152.09±33.27***
Triglycerides,mg dL−1 125.82±40.56 102.00±35.32**
Caloric intake, kcal d−1 3008.11±799.31 1540.28±378.16***
BMI, body mass index. Values are the mean ± SD (n = 11). Paired Student’s t-test was
performed to compare values before and after bilio-intestinal bypass. Asterisks indicate
statistical significance (**P < 0.01; ***P < 0.001).
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FIGURE 1 | Alpha diversity metrics (Chao 1, Shannon and Simpson indices) of OTU-level fecal bacterial communities from obese individuals; each
point represents a sample. Paired Student’s t-test was performed to compare alpha diversity estimates before and after bilio-intestinal bypass. Asterisks indicate
statistical significance (*P < 0.05; ***P < 0.001).
FIGURE 2 | Non-metric multidimensional scaling (NMDS) ordination
plot based on Bray-Curtis dissimilarities between OTU-level fecal
bacterial communities in obese individuals before and after
bilio-intestinal bypass.
taxonomic units (OTUs) obtained was 1244. Rarefaction curves
showed that, for each subject, bacterial species richness leveled off
as sampling depth increased, indicating that the sequencing effort
was sufficient and that the total diversity within the sample was
captured (Supplementary Figure 1). They also suggested that the
alpha diversity in pre-surgery samples was higher than in post-
surgery samples. To confirm this observation, Chao1 indexes
were calculated and evaluated by paired t-test (Figure 1). There
was a significant decrease in the mean microbial richness in
post-surgery subjects compared with pre-surgery (P = 0.018).
A diversity analysis based on Simpson and Shannon indexes
revealed that the diversity of the intestinal microbiota at the
OTU level was significantly higher in the fecal samples of pre-
surgery subjects compared with post-surgery (P = 0.0009 and
P = 0.0008, respectively). To compare the composition of
the intestinal microbiota of patients before and after surgery,
non-metric multi-dimensional scaling (NMDS) of a Bray-Curtis
distance matrix based on the abundance of OTUs was employed.
The NMDS revealed differences in the microbiota composition
based on surgery (Figure 2). An apparent clustering pattern
was identified for the participants before and after BIB. Points
representing the intestinal microbiota composition of obese
subjects and treated subjects clustered at the top left and the top
right, respectively.
Taxonomic Composition of Fecal Bacterial
Communities
Firmicutes, Actinobacteria, Bacteroidetes, Proteobacteria, and
Verrucomicrobia constituted the five dominant bacterial phyla
in the obese subjects under study, making up an average of 75.59,
21.62, 0.89, 0.82, and 1.05% of the total sequences, respectively
(Supplementary Figure 2). At the family level, the predominant
taxa were Veillonellaceae, Bifidobacteriaceae, Ruminococcaceae,
Lactobacillaceae, Lachnospiraceae, Erysipelotrichaceae, and
Clostridiaceae (data not shown). A portion (4.4%) of sequences
belonging to the order Clostridiales was not assigned to any
family. At the genus level, reads were assigned to 73 genera. A
barplot representation of genus-level sequence data showed high
inter-individual variability in the bacterial profile, indicating
that relative abundances of each genus varied a lot between
individuals, both before and after intervention (Figure 3B).
The most abundant genus in the gut of obese individuals
was Bifidobacterium, which accounted for 22.2% of the total
number of sequences in both pre- and post-surgery samples.
Lactobacillus was the second most abundant genus in post-
surgery individuals whereas Roseburia was the second most
abundant genus in pre-surgery samples. Megasphaera was
detected only in post-surgery individuals where it represented
16.1% of the sequences. Hierarchical clustering of the microbiota
community composition at the genus level showed that almost all
post-surgery profiles clustered separately from their pre-surgery
counterpart (Figure 3A).
Supervised Comparison of the Gut
Microbiota between Pre- and Post-surgery
Patients
Some of these microbial groups were present in different
concentrations in the feces of pre- vs. post-surgery individuals;
therefore, we attempted to highlight genera showing significant
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FIGURE 3 | Hierarchical clustering (A) and a barplot of relative abundances (B) of bacterial genera found within the fecal communities of obese
patients. Only genera with a relative abundance ≥5% in at least one subject are represented. The dendrograms were calculated using Spearman’s rank correlation
and Ward-linkage clustering.
differences. The linear discriminant analysis effect size (LefSE)
method identified a total of 31 bacterial groups that were
differentially abundant in obese individuals before and after
bariatric surgery (Figure 4 and Supplementary Figure 3). There
were 19 groups of bacteria enriched in the fecal samples of
pre-surgery individuals, namely, Clostridiales (the order and
its families Lachnospiraceae, Ruminococcaceae, Clostridiaceae,
and Eubacteriaceae); Coriobacteriales (the order and its family
Coriobacteriaceae); Carnobacteriaceae (the family and its genus
Granulicatella); and Lactococcus. Within Clostridiales, genera
with a linear discriminant analysis (LDA) score ≥4 were
Faecalibacterium (P = 0.0019), Ruminococcus (P = 0.0007),
Clostridium (P = 0.0001), Eubacterium (P = 0.0007),
and Blautia (P = 0.0003). The bacterial groups enriched
in post-surgery patients were Selenomonadales (the order,
its family Veillonellaceae, and the two genera Megasphaera
and Acidaminococcus), the family Enterobacteriaceae (from
phylum Proteobacteria to order Enterobacteriales), and the
genus Lactobacillus (from the class Bacilli to the family
Lactobacillaceae). Within these, genus Megasphaera had the
highest LDA score of 5.33 (P = 0.0002), followed by Lactobacillus
with a LDA of 4.93 (P = 0.0009) and Acidaminococcus with a
LDA of 4.00 (P = 0.035).
Associations between Key Bacterial
Populations and Host Parameters
Principal component analysis (PCA) (Supplementary Figure 4)
indicated that some putative correlations could exist between
significant bacterial populations and host clinical parameters.
Univariate linear mixed models were then used to substantiate
such relationships. Analysis revealed several significant
associations but, after adjusting for multiple testing, only five
models showed a P ≤ 0.20. Among them, positive associations
were found between Clostridium levels and blood insulin (B
= 0.728, P = 0.019; where B is the estimated standardized
regression coefficient and P the related P-value after Bonferroni
correction), Faecalibacterium and triglycerides (B = 0.610, P =
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FIGURE 4 | Histogram of the linear discriminant analysis (LDA) scores for differentially abundant bacterial clades in fecal samples between obese
individuals before and after bilio-intestinal bypass. Negative (red bars) LDA scores represent bacterial groups over-abundant in post-surgery samples while
positive (green bars) represent bacterial groups overrepresented in pre-surgery samples.
0.002), Gemmiger and serum glucose (B = 0.631, P = 0.053),
and total cholesterol and Clostridium (B = 0.696, P = 0.141).
There was a negative relationship between blood glucose and
the relative abundance of Lactobacillus (B = -0.551, P = 0.141).
To evaluate if such associations were influenced by variations
in dietary calories, bivariate linear mixed models were fitted
including caloric intake as a fixed effect. Only models in which
the collinearity among predictors was not significant were run.
Among these, associations between glucose and Gemmiger (B
= 0.469, P = 0.0006), glucose and Lactobacillus (B = −0.385,
P= 0.0065), and triglycerides and Faecalibacterium (B =
0.592, P = 0.0002) remained significant even when controlling
for caloric intake. In the first two aforementioned models,
caloric intake displayed a significant positive association with
glucose (B = 0.360 and 0.347, respectively, with associated P =
0.0021 and 0.0079, respectively), thus showing a simultaneous
independent effect on blood glucose concentration; while, there
was no significant association in the last model (B = 0.035,
P = 0.7066).
Quantification of Functional Bacterial
Groups
Real-time PCR analysis was performed to detect bacterial
functional groups whose metabolic activities play a key
role in human colon metabolism. The qRT–PCR of the
butyryl-CoA:acetate CoA-transferase (BCoAT) gene, involved in
the microbial production of butyrate, indicated that the average
abundance of the BcoAT gene was significantly reduced by about
2 log in post-surgery subjects compared with pre-surgery (7.68±
0.69 vs. 6.05± 1.15 log10 gene copies g
−1, P = 0.0048) (Figure 5).
Mean acetogenic bacteria levels were significantly lower in post-
surgery subjects than in pre-surgery individuals (7.68 ± 0.85
vs. 9.21 ± 0.73 log10 gene copies g
−1, P = 0.0019) (Figure 5).
Similarly, there was a significant post-surgery reduction in the
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mean number of methanogens (4.93 ± 0.70 log10 gene copies
g−1) compared with baseline (5.95 ± 1.01 log10 gene copies g
−1,
P = 0.001). In contrast, quantitative PCR of the dissimilatory
(bi)sulfite reductase gene revealed that mean levels of sulfate-
reducing bacteria were similar in the two groups (Figure 5).
Bacterial Metabolism Products in Fecal
Samples
The pH of fecal samples was significantly lower in post-surgery
subjects compared with pre-surgery (5.72 ± 0.70 vs. 6.74 ±
0.74, P = 0.008). No statistically significant difference was found
between the mean levels of urea in fecal samples from subjects
pre-surgery compared with post-surgery (Figure 6). Both L-
lactate andD-lactate increased in post-surgery subjects; although,
such differences did not reach statistical significance. Relative
to pre-surgery samples, there were significantly lower levels
of acetate (42.63 ± 16.34 vs. 62.40 ± 19.39% of total short
chain fatty acids (SCFA), P = 0.0117) and propionate (11.94
± 8.750 vs. 23.42 ± 10.95% of total SCFA, P = 0.0049) in
the post-surgery samples. On the contrary, the fecal samples
from post-surgery individuals had significantly higher levels of
valerate (8.956 ± 8.390 vs. 2.258 ± 1.660% of total SCFA, P
= 0.0162) and hexanoate (4.117 ± 4.364 vs. 0.4600 ± 0.7202%
of total SCFA, P = 0.0039) compared with pre-surgery samples
(Figure 6). The fecal content of butyrate did not significantly vary
in post-surgery patients compared with pre-surgery. When we
tested for associations between the relative abundance of bacterial
genera and fecal metabolite parameters, we observed significant
positive relationships between hexanoate percentage levels and
Megasphaera (B = 0.899, P = 0.0008) and valerate percentage
levels andMegasphaera (B= 0.773, P = 0.04).
DISCUSSION
In our study, obese patients had high mean levels of Firmicutes
and low levels of Bacteroidetes in their fecal samples, when
evaluated by Illumina 16S rDNA sequencing. Several authors
have pointed out that human obesity is associated with high
gut concentrations of Firmicutes and low concentrations of
Bacteroidetes compared with lean individuals (Ley et al., 2006;
Turnbaugh et al., 2009). This finding was not supported by other
studies (Duncan et al., 2008; Schwiertz et al., 2010) and a recent
analysis of data retrieved from the Human Microbiome Project
(HMP) and MetaHIT survey showed no association between
obesity and the Bacteroidetes-to-Firmicutes ratio (Finucane
et al., 2014). Notably, there are reports of reduced Firmicutes
and increased Bacteroidetes in obese subjects after weight loss
induced by either gastric bypass (Zhang et al., 2009; Kong
et al., 2013) or dietary restriction (Ley et al., 2006; Duncan
et al., 2008). In this study, we did not observe either a decrease
in Firmicutes abundance or an increase in Bacteroidetes in
BIB-treated patients after surgery, i.e., the Bacteroidetes and
Firmicutes bacterial populations shifting to proportions more
like those usually found in lean individuals. Interestingly, the
amounts of fecal Bacteroidetes detected in our study population
were very much lower than those previously estimated in human
obese individuals. The source of this discrepancy is unknown, but
potential factors influencing the observed pattern include obesity
grade, comorbid conditions, energy intake, age, population size,
geographical location.
At lower taxonomic rank, we found several bacterial features
that most likely explain the differences between pre- and
post-surgery fecal microbiota. The bacterial genera within the
Firmicutes phylum that were abundant in obese individuals
FIGURE 5 | Abundance of metabolic functional genes in the fecal microbiota of obese individuals before and after bariatric surgery as determined by
qRT–PCR. Genes targeted included BcoAT for butyrate producers, acs for acetogens, mcrA for methanogens, and dsrA for sulfate reducers. Values are log means ±
SD. Paired Student’s t-test was performed on log-transformed data. Asterisks indicate statistical significance (**P < 0.01; ***P < 0.001).
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FIGURE 6 | Levels of bacterial metabolites in the fecal samples of obese individuals before and after bilio-intestinal bypass. Individual short chain
fatty acids (SCFAs) are shown as mean percentages of the total SCFA concentration. Values are means ± SD. Wilcoxon signed-rank test was performed to
compare metabolites values before and after bilio-intestinal bypass. Asterisks indicate statistical significance (*P < 0.05; **P < 0.01).
included mostly members of the order Clostridiales. Several
authors have reported enrichment of Clostridium cluster XIVa
(Verdam et al., 2013), Roseburia intestinalis (Tims et al., 2013;
Verdam et al., 2013), and Eubacterium rectale (Ferrer et al.,
2013; Tims et al., 2013) in the gut of obese subjects. In addition,
pre-surgery obese individuals had increased Coriobacteriaceae.
Members of the family Coriobacteriaceae represent dominant gut
bacteria that are not well studied; although, they have important
metabolic functions such as the conversion of bile salts and
steroids that may influence host lipid metabolism. In support of
this, studies in rodents determined that the abundance of this
bacterial group significantly correlated with triglyceride levels or
non-HDL cholesterol levels (Martínez et al., 2009; Claus et al.,
2011). In post-surgery patients, the LefSE method showed a
significant increase in Proteobacteria (Gammaproteobacteria),
specifically Enterobacteriaceae, compared with pre-surgery. This
result is in agreement with previous studies on the effects of
Roux-en-Y gastric bypass on gut microbiota that showed a
substantial shift toward higher concentrations of Proteobacteria
after surgery in both humans and rats (Zhang et al., 2009; Li
et al., 2011; Graessler et al., 2013; Kong et al., 2013). In addition,
the fecal microbiota of post-surgery patients was significantly
enriched in bacterial taxa belonging to the order Lactobacillales
and Selenomonadales, in particular the genera Lactobacillus,
Acidaminococcus, and Megasphaera. The Lactobacillus spp.
produce lactic acid and derive energy from the fermentation of
lactose, glucose, and other sugars; while, Acidaminococcus spp.
are among the predominant amino acid-fermenting microbiota
along the digestive tract of humans and animals. Glucose and
amino acid absorption mainly take place in the small intestine,
so it is tempting to speculate that small intestinal resection, by
increasing the amount of simple sugars and amino acids reaching
the large intestine, may trigger colon bacteria that can use mal-
absorbed nutrients as an energy source. This mechanism has been
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described in human short bowel syndrome, where fermentation
of non-digested carbohydrates in the large bowel can lead to a
decrease in luminal pH as a result of the overgrowth of D-lactate
producing bacteria, such as Lactobacillus spp. (Buchman et al.,
2003; Zhang et al., 2003). Consistent with this, we observed a
significant decrease of pH in fecal samples from post-surgery
individuals, together with an increase in lactic acid, although the
latter did not reach statistical significance. It seems also likely that
an increased activity of lactate-producing bacteria in the distal
gut may be linked to the augmented numbers of Megasphaera
after surgery. Megasphaera elsdenii, the most studied of the
Megasphaera spp., is known to actively ferment lactate in the
rumen, thereby reducing acidosis in ruminants (Marounek et al.,
1989). It has been suggested thatMegasphaera spp. isolated from
the human gut may serve a similar function (Shetty et al., 2013).
To gain further insight into the microbial community shifts
associated with BIB, we evaluated the abundances of functional
bacterial groups. We detected a significant decrease in the
BCoAT gene post-surgery. This result is not unexpected, since
production of butyrate through BCoAT appears to be a common
underlying feature of bacteria within the class Clostridia (Louis
et al., 2010). Among hydrogenotrophic gut bacteria, a significant
decrease of acetogenic bacteria was found after BIB. These
results are in line with data from Illumina sequencing of 16S
rRNA gene amplicons, in that several bacterial groups that
were significantly reduced in stool from post-surgery patients,
including the genera Ruminococcus, Clostridium, and Blautia,
are known acetate producers (Chassard and Bernalier-Donadille,
2006). Analogously, we found a reduction of methanogenic
Archaea after bariatric surgery using quantitative PCR with
mcrA primers. These findings confirm results from Furet et al.
(2010) and Zhang et al. (2009). Our results from acetogenic
and methanogenic populations seem to further support the
hypothesis of Zhang et al. (2009) that, in obese individuals,
methanogens, and likely acetogens, accelerate the fermentation
of indigestible polysaccharides by lowering the partial pressure of
hydrogen. Thus, the energy harvesting from the diet is increased.
Notably, we did not find any significant changes in the levels
of sulfate-reducing bacteria in post-surgery patients compared
with pre-surgery. One explanation for this is that the metabolism
of sulfate-reducing bacteria is much more versatile than that of
acetogens and methanogens since they can oxidize a variety of
organic compounds such as lactate (Marquet et al., 2009) and can
persist under different environmental conditions (Muyzer and
Stams, 2008).
The observed shifts in bacterial populations between obese
subjects before and after BIB led us to investigate potential
changes in the gut environment conditions and fermentation
parameters. The post-surgical decrease of pH points toward an
altered intestinal environment that could reasonably influence
gut microbial ecology, as indicated previously (Walker et al.,
2005). Studies in animal models have shown that the obese
microbiota differs from the lean microbiota and may produce
more SCFAs and, hence, extract more energy from a given
diet than the lean microbiota (Turnbaugh et al., 2006). Recent
studies have also shown that fecal SCFA concentrations were
significantly higher in obese subjects compared with lean
participants (Schwiertz et al., 2010). However, in our study, we
did not detect any significant variations in the mean levels of
total SCFAs and butyrate in obese individuals before and after
bariatric surgery. Although, it must be stressed that a real-time
PCR assay targeting the BcoAT gene indicated a decrease of
butyrate producers in the gut of surgical patients. In a recent
study conducted in swine, several isolated strains, including M.
elsdenii, did not have BcoAT genes detectable by degenerate PCR
assay; although, they all had BcoAT enzyme activity. Authors
suggested that the degenerate primers for BcoAT genes could
underestimate the abundance of butyrate-producing bacteria and
should be broadened to capture more butyrate producers in the
gut (Levine et al., 2013). In the study by Liou et al. (2013), the
RYGB mice had decreased total SCFAs compared with sham
mice, with reductions in acetate levels and a relative increase in
propionate levels. In our obese patients, the ratios of individual
SCFAs are altered, with decreased acetate and propionate as well
as increased valerate and hexanoate fecal concentrations. Such
compounds are related to gut bacterial metabolism; thus, it is
likely that variations in the SCFA profile of post-surgery patients
reflect the specific composition of the gut microbial community.
When we attempted to find linear relationships between bacterial
groups and metabolites, we found that hexanoate and valerate
levels were significantly associated with the relative proportion
of Megasphaera spp. This is not surprising, since the rumen
bacterium M. elsdenii reportedly produces valerate and caproate
from redox-neutral substrates (sugars or lactate) (Marounek
et al., 1989). It is can be hypothesized that the final concentrations
of butyrate, acetate, and propionate in feces are the result of not
only shifts in the direct production by microbial populations,
but also of the interspecies cross-feeding interactions occurring
in the distal gut. Further studies are necessary to elucidate
the potential contributions of the specific microbial-derived
metabolite changes on host colonic function and energy balance
after BIB. In this regard, butyrate is the major energy source
among SCFAs for colonocytes; while, acetate and propionate are
absorbed into portal circulation. Propionate is largely taken up by
the liver and consumed for gluconeogenesis; however, acetate is
metabolized by peripheral tissues for de novo lipogenesis (Wong
et al., 2006). Jørgensen et al. (1997) suggested that valerate and
caproate are excellent substrates for oxidation in rat colonocytes,
similar to butyrate. In addition to being used as an energy
source for the host, the signaling properties of SCFAs could
indicate a putative contribution to the changes associated with
patients before and after the intervention. The SCFAs are ligands
for the G protein–coupled receptors Gpr41 and Gpr43. Acetate
exhibits higher potency at the human GPR43, whereas valerate
and caproate have higher potency at human GPR41 (Brown et al.,
2003; Le Poul et al., 2003). Notably, a growing body of evidence
links GPR43 to body weight andmetabolic disorders (Hong et al.,
2005; Ge et al., 2008; Bjursell et al., 2011). Data in several animal
studies have highlighted a role of GPR41 in regulating host
energy balance, in particular by acting on sympathetic activity
and intestinal gluconeogenesis (Samuel et al., 2008; Kimura et al.,
2011; De Vadder et al., 2014).
Despite the small size of the study cohort, we succeeded in
highlighting a few significant associations between alterations
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in metabolic indices and changes in the composition of the
gut microbiota. In particular, Lactobacillus, which was up-
regulated after surgery, was negatively correlated with blood
glucose. When looking at probiotic applications in humans
and animal models, Lactobacillus spp. are effective in the
regulation of glucose metabolism (Panwar et al., 2013). We found
positive associations involving bacterial genera that decreased
after BIB, such as Clostridium and blood insulin and total
cholesterol, Faecalibacterium and triglycerides, and Gemmiger
and blood glucose. Since dietary intake was significantly reduced
after surgery, we verified such associations by controlling for
the potential confounding effect of diet. After the statistical
adjustment for caloric intake, these associations remained
significant, indicating that the highlighted relationships between
these bacterial populations (with the exception of Clostridium,
which showed significant collinearity with caloric intake) and
clinical parameters were independent of caloric intake. These
results are in agreement with those of Kong et al. (2013) that
found the populations of gut microbiota can be modulated
via bariatric surgery independently of the variation in caloric
consumption (Kong et al., 2013).
The present study has some limitations that have to be
acknowledged. Obese patients experienced a marked decrease
of body weight subsequent to the BIB as well as a significant
reduction in caloric intake. The present sample size of 11
may be insufficient for highlighting every significant correlation
pattern between gut microbiota and clinical parameters, and
the observed correlations may be partly associated with other
confounding variables. Regardless of the relevance of BIB for
clinical practice, our study contributed to the identification of
gut microbial populations and metabolite profiles that could
represent putativemarkers of obesity, as well asmarkers of weight
loss and metabolic improvement following bariatric surgery.
These findings warrant further investigation to evaluate the exact
impact of surgically-induced changes in human gut microbiota
on host physiology and health. A deeper understanding of
host-microbial crosstalk might help in the development of
new alternative strategies as well as approaches to supplement
bariatric surgery in the treatment of obesity and related co-
morbidities.
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Supplementary Figure 1 | Normalized rarefaction curves displaying the
average number of OTUs (at 97% similarity) discovered by random
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line) and after (red line) bilio-intestinal bypass.
Supplementary Figure 2 | Hierarchical clustering (A) and a barplot of
relative abundances (B) of bacterial phyla found within the fecal
communities of obese patients. The dendrograms were calculated using
Spearman’s rank correlation and Ward-linkage clustering.
Supplementary Figure 3 | Cladogram indicating the phylogenetic
distribution of differentially abundant bacterial lineages in fecal samples
between obese individuals before and after bilio-intestinal bypass,
determined by linear discriminant analysis (LDA). Red dots represent
bacterial groups over-abundant in post-surgery samples, while green dots
represent bacterial groups overrepresented in pre-surgery samples.
Supplementary Figure 4 | Biplot of the first two principal components from
the principal component analysis (PCA) of bacterial genera relative
abundances and bio-clinical markers. The length of the vectors represents the
PCA loadings of the variables on the first two principal components. Dots
represent individual subjects before (solid circles) and after (open circles)
bilio-intestinal bypass.
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